Epithelial-mesenchymal transition, cancer stem cells and …

Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ: Effect of screening and adjuvant therapy on mortality from breast cancer.

N Engl J Med 2005, 353:1784-1792. PubMedAbstract | PublisherFullText

Fong P: Mouse models for human epithelial disease: novel insights and new horizons.

Exp Physiol 2009, 94:169-170. PubMedAbstract | PublisherFullText

Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Tham YL, Kalidas M, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, Lewis MT, Wong H, O'Connell P: Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

J Clin Oncol 2005, 23:1169-1177. PubMedAbstract | PublisherFullText

Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC: Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

J Natl Cancer Inst 2008, 100:672-679. PubMedAbstract | PublisherFullText

Kalluri R, Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis.

J Clin Invest 2003, 112:1776-1784. PubMedAbstract | PublisherFullText | PubMedCentralFullText

Continued here:
Epithelial-mesenchymal transition, cancer stem cells and ...